---
figid: PMC9659209__cancers-14-05472-g001
figtitle: 'Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?'
organisms:
- Mus musculus
- Helicobacter pylori SS1
- Human gammaherpesvirus 4
- Adenoviridae
- Helicobacter pylori
- Nicotiana tabacum
- Saccharomyces cerevisiae
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC9659209
filename: cancers-14-05472-g001.jpg
figlink: /pmc/articles/PMC9659209/figure/cancers-14-05472-f001/
number: F1
caption: Role of HDAC1 in different signaling pathways involved in GC progression.
  HDAC1 promotes GC cell proliferation via lncRNA HRCEG repression, lncRNAs BC01600
  and AF116637 upregulation, or MORC2/p21 pathway. HDAC1 favors metastatic abilities
  of GC cells through miR-34a repression inducing CD44 expression. HDAC1 promotes
  HIF-1α activity leading to glycolysis in GC cells. HDAC1 inhibits CRADD transcription
  and consequently caspase-2-dependent apoptosis. HDAC1 is a resistance factor to
  chemotherapies in GC such as anthracycline, via repression of CITED2, and doxorubicin,
  inhibiting its fixation on DNA. Figure has been generated using Biorender (Biorender.com).
papertitle: 'Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?.'
reftext: Amandine Badie, et al. Cancers (Basel). 2022 Nov;14(21):5472.
year: '2022'
doi: 10.3390/cancers14215472
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: histone deacetylase | histone deacetylase inhibitor | gastric cancer | biomarker
automl_pathway: 0.9568051
figid_alias: PMC9659209__F1
figtype: Figure
redirect_from: /figures/PMC9659209__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9659209__cancers-14-05472-g001.html
  '@type': Dataset
  description: Role of HDAC1 in different signaling pathways involved in GC progression.
    HDAC1 promotes GC cell proliferation via lncRNA HRCEG repression, lncRNAs BC01600
    and AF116637 upregulation, or MORC2/p21 pathway. HDAC1 favors metastatic abilities
    of GC cells through miR-34a repression inducing CD44 expression. HDAC1 promotes
    HIF-1α activity leading to glycolysis in GC cells. HDAC1 inhibits CRADD transcription
    and consequently caspase-2-dependent apoptosis. HDAC1 is a resistance factor to
    chemotherapies in GC such as anthracycline, via repression of CITED2, and doxorubicin,
    inhibiting its fixation on DNA. Figure has been generated using Biorender (Biorender.com).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TF
  - HDAC1
  - HDAC2
  - MIR520H
  - CITED2
  - SLC25A25-AS1
  - MIR34A
  - MORC2
  - HIF1A
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CD44
  - Hdac1
  - Hdac1-ps
  - Hdac2
  - Cited2
  - Mir34a
  - Hif1a
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Cd44
  - tf
  - HDAC6
  - mmm
  - hh
  - ra
  - sima
  - Gclm
  - dap
  - Doxorubicin
  - AF116637
  - laia taia
---
